gsk2118436
Showing 1 - 11 of 11
Cancer Trial in Worldwide (GSK2118436, GSK1120212, Other approved anti-cancer agent)
Completed
- Cancer
- GSK2118436
- +2 more
-
Goodyear, Arizona
- +43 more
Mar 20, 2019
Cancer Trial in Tacoma (GSK2118436)
Completed
- Cancer
- GSK2118436
-
Tacoma, WashingtonGSK Investigational Site
Nov 8, 2017
Cancer Trial in Tacoma (GSK2118436)
Completed
- Cancer
- GSK2118436
-
Tacoma, WashingtonGSK Investigational Site
Nov 8, 2017
Cancer Trial in Shizuoka, Tokyo (GSK2118436)
Completed
- Cancer
- GSK2118436
-
Shizuoka, Japan
- +1 more
Nov 8, 2017
Papillary Thyroid Carcinoma Trial in Boston (GSK2118436)
Completed
- Papillary Thyroid Carcinoma
- GSK2118436
-
Boston, MassachusettsMassachusetts General Hospital
Jan 24, 2017
Melanoma Trial in Houston (GSK2118436, GSK1120212)
Completed
- Melanoma
- GSK2118436
- GSK1120212
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Oct 19, 2016
Melanoma and Brain Metastases Trial in Worldwide (GSK2118436)
Completed
- Melanoma and Brain Metastases
- GSK2118436
-
Los Angeles, California
- +23 more
Apr 24, 2014